lobbying_activities: 1989282

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1989282	c94ba27c-4424-40c3-a306-448f97f9fdf4	Q2	SAFEWAY INC.	300173	SAFEWAY	2017	second_quarter	PHA	H.R. 592, S. 109 - The Pharmacy and Medically Underserved Areas Enhancement Act, all provisions. H.R. 1038/S. 413 - Improving Transparency and Accuracy in Medicare Part D Spending Act, all provisions. H.R. 2430 - FDA Reauthorization Act of 2017, amendments related to importation of prescription drugs Implementation of 2017 NDAA Tricare Pilot.	HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2017-07-17T13:51:32.467000-04:00